Summary
Canada only - etanercept derm (NCT01313221)
Summary
ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results
Summary
Efficacy and safety results of ABT-874 vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Summary
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial
Summary
A phase 3, multi site, randomized, double blind, placebo controlled study of the efficacy and safety comparing CP- 690,550 and etanercept in subjects with moderate to severe chronic plaque psoriasis (NCT01241591)
Summary
Study to evaluate the efficacy, and safety of adding topical therapy to etanercept in subjects with moderate to severe plaque psoriasis (NCT01235442)
Summary
ABT-874 versus etanercept and placebo in patients with moderate-to-severe chronic plaque psoriasis: Efficacy and safety results
Summary
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
Summary
A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction
Summary
A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction
This site complies with the HONcode standard for trustworthy health information: